Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Mar, N; Friedlander, TW; Hoimes, CJ; Flaig, TW; Bilen, MA; Balar, AV; Henry, E; Srinivas, S; Rosenberg, JE; Petrylak, DP; Burgess, EF; Merchan, JR; Tagawa, ST; Carret, A-S; Steinberg, JL; Chaney, MF; Milowsky, MI

Published Date

  • May 20, 2020

Published In

Volume / Issue

  • 38 / 15

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X